Dual-Biomarker Oral-Rinse Testing for aMMP-8 and Calprotectin: A Potential Adjunctive Tool for Risk Stratification and Interdisciplinary Referral in Periodontitis and Type 2 Diabetes
Authors:
- Pietro LeonePietro Leone
- Ismo T. RäisänenIRIsmo T. Räisänen
- Julie Toby ThomasJTJulie Toby Thomas
- Pirjo PärnänenPPPirjo Pärnänen
- Sukumaran AnilSukumaran Anil
- Andreas GrigoriadisAGAndreas Grigoriadis
- Dimitra SakellariDSDimitra Sakellari
- Pierino di SilverioPSPierino di Silverio
- Marco EvangelistaMEMarco Evangelista
- Timo SorsaTSTimo Sorsa
Open Access
- 8 September 2026
- journal article
- review article
- Published by MDPI AG in Bioengineering
- Vol. 13 (9) , 1042
Abstract
Periodontitis is a chronic, biofilm-induced inflammatory disease characterized by episodic connective tissue destruction and is epidemiologically associated with cardiometabolic conditions, notably type 2 diabetes (T2D) and cardiovascular disease (CVD). Conventional clinical signs do not reliably distinguish quiescent from actively progressing disease, which delays intervention and interdisciplinary referral. Chair-side point-of-care testing (POCT) of oral fluids offers a pragmatic, non-invasive adjunct for real-time assessment of disease activity, not only in dental but also in medical settings. This narrative review, reported in line with the Scale for the Assessment of Narrative Review Articles (SANRA), examines the clinical rationale and current evidence for oral-rinse POCT targeting active matrix metalloproteinase-8 (aMMP-8) and calprotectin. Oral-rinse aMMP-8 reflects disease-active collagenolysis and shows the more robust single-marker performance for periodontitis, whereas oral-fluid calprotectin, a neutrophil-derived S100A8/A9 protein, behaves as a predominantly local inflammatory signal and lacks validated oral-fluid reference ranges. Combining the two markers may add information beyond either alone when used in tandem as a complementary pair, but the supporting data are heterogeneous, largely exploratory, and hypothesis-generating. Dual-biomarker oral-rinse POCT is therefore best framed as a risk-stratification and referral aid rather than a stand-alone diagnostic, with combined interpretation potentially supported by AI technologies. Standardized pre-analytics, transparent threshold reporting, oral-fluid calprotectin reference values, and prospective multicenter validation are required before broad implementation.Keywords
This publication has 102 references indexed in Scilit:
- Levels of IL‐1β, MMP‐8, and MMP‐9 in the Saliva of Subjects With Periodontitis: A Systematic Review and Meta‐AnalysisJournal of Clinical Laboratory Analysis, 2025
- Evaluation of salivary interleukin‐17 and developmental endothelial locus‐1 in patients with periodontitis with and without type 2 diabetes mellitusJournal of Periodontology, 2024
- Precision periodontal care: from omics discoveries to chairside diagnosticsClinical Oral Investigations, 2023
- Association between periodontitis and metabolic syndrome in the Hamburg City Health StudyJournal of Periodontology, 2021
- Prediabetes/diabetes screening strategy at the periodontal clinicClinical and Experimental Dental Research, 2020
- Salivary biomarkers in the context of gingival inflammation in children with cystic fibrosisJournal of Periodontology, 2020
- Staging and grading of periodontitis: Framework and proposal of a new classification and case definitionJournal of Periodontology, 2018
- Association of metabolic syndrome and chronic periodontitis in ColombiansClinical Oral Investigations, 2016
- Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patientsClinical Oral Investigations, 2013
- Periodontitis and diabetes: a two-way relationshipDiabetologia, 2011